These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2820374)

  • 1. Therapeutic effect of captopril once-daily in essential hypertension.
    Gil V; Lahera V; Beneyto MC; Lopez-Vidriero E; Rodriguez FJ
    Bibl Cardiol; 1987; (42):152-5. PubMed ID: 2820374
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of essential arterial hypertension of moderate severity with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
    Guerrera G; Melina D
    Minerva Cardioangiol; 1983 Mar; 31(3):101-6. PubMed ID: 6304570
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diuretic-resistant hypertension. Effect of an additional daily single dose of a ACE inhibitor].
    Baumgart P; Tenschert W; Vetter H
    Schweiz Med Wochenschr; 1985 Dec; 115(50):1832-4. PubMed ID: 3003892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of captopril once daily on blood pressure and angiotensin converting enzyme in hypertensive patients.
    Rodriguez FJ; Gil V; del Carmen Beneyto M; Lopez-Vidriero E
    Postgrad Med J; 1986; 62 Suppl 1():94-6. PubMed ID: 2825151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension.
    Favrat B; Burnier M; Nussberger J; Lecomte JM; Brouard R; Waeber B; Brunner HR
    J Hypertens; 1995 Jul; 13(7):797-804. PubMed ID: 7594444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness and tolerance of benazepril versus captopril in patients with hypertension].
    Ol'binskaia LI; Golubev SA; Morozova TE
    Klin Med (Mosk); 1995; 73(5):36-8. PubMed ID: 8815273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cilazapril replacing captopril in the therapy of medium-severe essential hypertension].
    Kovács P; Juhász A; Gábeli T; Karányi Z; Polgár P; Paragh G; Lörincz I; Arnold C
    Orv Hetil; 1995 Oct; 136(42):2273-8. PubMed ID: 7478470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy and safety of trandolapril and captopril for 16 weeks in mild-to-moderate essential hypertension. Investigator Study Group.
    Pauly NC; Safar ME
    J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S73-6. PubMed ID: 7527106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Administration of captopril (aceten++, ++"Vokhardt"++) in hypertension and congestive heart failure].
    Balakhonova NP; Avdeev VG; Kuznetsov NE; Liapon DO; Senchikhin PV
    Klin Med (Mosk); 1997; 75(1):42-3. PubMed ID: 9082059
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship between vasopressin and the renin-angiotensin-aldosterone system in essential hypertension: effect of converting enzyme inhibitor on plasma vasopressin.
    Santucci A; Leonetti Luparini R; Ferri C; Ficara C; Giarrizzo C; Balsano F
    J Hypertens Suppl; 1985 Nov; 3(2):S133-4. PubMed ID: 3003302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of captopril on serum angiotensin converting enzyme and blood pressure in hypertensive patients.
    Singh R; Kalra OP; Sarma PU; Prabhu KM
    J Assoc Physicians India; 1996 Feb; 44(2):109-11. PubMed ID: 10999062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute inhibition of angiotensin-converting enzyme by captopril. Hemodynamic and biochemical aspects in normotension and essential hypertension].
    Stanek B; Templ H; Pohanka E; Silberbauer K
    Acta Med Austriaca; 1982; 9(5-6):175-80. PubMed ID: 6299046
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients.
    Paran E; Anson O; Neumann L
    Am J Hypertens; 1996 Dec; 9(12 Pt 1):1206-13. PubMed ID: 8972892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
    Rosei EA; Rizzoni D;
    J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
    Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
    Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with converting-enzyme inhibitors in hypertension.
    Weber MA
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):45-51. PubMed ID: 3037889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination of angiotensin-converting enzyme inhibitors and calcium antagonists: an effective therapeutic regimen in hypertensive crisis].
    Martínez-Amenós A; Carratalá J; Pintó X; Santaló M; Tamayo C; Pujol M
    Med Clin (Barc); 1987 Nov; 89(16):681-3. PubMed ID: 3320601
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amlodipine and captopril in moderate-severe essential hypertension.
    Maclean D; Mitchell ET; Wilcox RG; Walker P; Tyler HM
    J Hum Hypertens; 1988 Aug; 2(2):127-32. PubMed ID: 2977406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.